icatibant acetate

FDA Drug Profile — ICATIBANT, Firazyr

Drug Details

Generic Name
icatibant acetate
Brand Names
ICATIBANT, Firazyr
Application Number
ANDA212081
Sponsor
Bryant Ranch Prepack
NDC Codes
2
Dosage Forms
INJECTION, SOLUTION
Routes
SUBCUTANEOUS
Active Ingredients
ICATIBANT ACETATE

Indications and Usage

1 INDICATIONS AND USAGE FIRAZYR ® (icatibant) is indicated for the treatment of acute attacks of hereditary angioedema (HAE) in adults 18 years of age and older. FIRAZYR is a bradykinin B2 receptor antagonist indicated for treatment of acute attacks of hereditary angioedema (HAE) in adults 18 years of age and older. ( 1 )